[HTML][HTML] Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - pure.johnshopkins.edu
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - ui.adsabs.harvard.edu
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
[HTML][HTML] Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - ncbi.nlm.nih.gov
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies.
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - search.ebscohost.com
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging reveals excellent brain penetration in animal models of TB meningitis and first-in-human studies
F Mota, C Ruiz-Bedoya, E Tucker, D Holt, P De Jesus… - 2022 - researchsquare.com
Pretomanid is a nitroimidazole antimicrobial with potent activity against drug-resistant
Mycobacterium tuberculosis and approved in combination with bedaquiline and linezolid …
Mycobacterium tuberculosis and approved in combination with bedaquiline and linezolid …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker, DP Holt… - Nature …, 2022 - ideas.repec.org
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies.
F Mota, CA Ruiz-Bedoya, EW Tucker, DP Holt… - Nature …, 2022 - europepmc.org
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - econpapers.repec.org
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
F Mota, CA Ruiz-Bedoya, EW Tucker… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Pretomanid is a nitroimidazole antimicrobial active against drug-resistant Mycobacterium
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …
tuberculosis and approved in combination with bedaquiline and linezolid (BPaL) to treat …